Unibest
← Back to patent-cliff list

CAS 167095-12-7

(1E)-3-Ethoxy-3-oxo-1-phenyl-1-[(phenylcarbonyl)amino]prop-1-en-2-yl ethyl ethanedioate

Codes: (V)101438-50-a

Application context (from source-drug indications)

Breast cancerPaclitaxel/Encequidar mesylateAdenocarcinomaPaclitaxel/Encequidar mesylateAngiosarcomaPaclitaxel/Encequidar mesylateSolid tumourPaclitaxel/Encequidar mesylatePancreatic cancerPaclitaxelNon-small cell lung cancerPaclitaxelHodgkin's diseasePaclitaxelSeminomaPaclitaxelOvarian cancerPaclitaxelBreast cancerPaclitaxel

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylateTier C — Watch / trade-
PaclitaxelTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Paclitaxel/Encequidar mesylateOptimised routesteps: 5total yield: /
(±)-alpha-Aminophenylacetic acid→alpha-Chlorobenzaldehyde→2-Phenyl-2-(phenylformamido)acetic acid→1-(Chlorocarbonyl)formic acid ethyl ester→(1E)-3-Ethoxy-3-oxo-1-phenyl-1-[(phenylcarbonyl)amino]prop-1-en-2-yl ethyl ethanedioate→Ethyl 2-oxo-3-phenyl-3-[(phenylcarbonyl)amino]propanoate→(±)-Ethyl (2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoate→(2R,3S)-2-Hydroxy-3-phenyl-3-(phenylformamido)propanoic acid
PaclitaxelOptimised routesteps: 5total yield: /
(±)-alpha-Aminophenylacetic acid→alpha-Chlorobenzaldehyde→2-Phenyl-2-(phenylformamido)acetic acid→1-(Chlorocarbonyl)formic acid ethyl ester→(1E)-3-Ethoxy-3-oxo-1-phenyl-1-[(phenylcarbonyl)amino]prop-1-en-2-yl ethyl ethanedioate→Ethyl 2-oxo-3-phenyl-3-[(phenylcarbonyl)amino]propanoate→(±)-Ethyl (2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoate→(2R,3S)-2-Hydroxy-3-phenyl-3-(phenylformamido)propanoic acid

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.